The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
INFLUENTIAL PUBLICATIONFull Access

Bibliography for Bipolar Disorder

Published Online:https://doi.org/10.1176/foc.1.1.32

This section of the journal contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. The entries for the bibliography are listed in reverse chronological order. Articles from the bibliography that are reprinted in this issue are in bold.

Frank E, Kupfer DJ, Gibbons R, Houck P, Kostelnik B, Mallinger AG, Swartz HA, Thase ME: Interpersonal and social rhythm therapy prevents depressive symptomatology in patients with bipolar I disorder. Arch Gen Psychiatry (in press)

Baldessarini RJ, Tondo L, Hennen J, Viguera AC: Is lithium still worth using? An update of selected recent research. Harvard Rev Psychiatry 2002; 10(2):59–75

Benazzi F: Highly recurrent unipolar may be related to bipolar II. Compr Psychiatry 2002; 43:263–268

Rucci P, Frank E, Kostelnik B, Fagiolini A, Mallinger AG, Swartz HA, Thase ME, Siegel L, Wilson D, Kupfer DJ: Suicide attempts in patients with bipolar I disorder during acute and maintenance phases of intensive treatment with pharmacotherapy and adjunctive psychotherapy. Am J Psychiatry 2002; 159:1160–1164

Fava GA, Bartolucci G, Rafanelli C, Mangelli L: Cognitive-behavioral management of patients with bipolar disorder who relapsed while on lithium prophylaxis. J Clin Psychiatry 2001; 62:556–559

Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158:906–912

Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G: Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 2001; 3:CD003013

Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis- Siotis I: Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157:124-126

McElroy SL, Keck PE Jr: Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry 2000; 48:539–557

Manji HK, Moore GJ, Rajkowska G, Chen G: Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 2000; 5:578–593

Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ (Divalproex Maintenance Study Group): A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57:481–489

Berrettini WH: Genetics of psychiatric disease. Annu Rev Med 2000; 51:465–479

Baldessarini RJ, Tohen M, Tondo L: Maintenance treatment in bipolar disorder. Arch Gen Psychiatry 2000; 57:490–492

Miklowitz DJ, Simoneau TL, George EL, Richards JA, Kalbag A, Sachs-Ericsson N, Suddath R: Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biol Psychiatry 2000; 48:582–592

Wisner KL, Zarin DA, Holmboe ES, Appelbaum PS, Gelenberg AJ, Leonard HL, Frank E: Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000; 157:1933–1940

Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Locatelli G, Leverich GS, Post RM: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20:607–614

Frank E, Swartz HA, Kupfer DJ: Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry 2000; 48:593–604

Post RM, Frye MA, Denicoff KD, Leverich GS, Dunn RT, Osuch EA, Speer AM, Obrocea G, Jajodia K: Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review. Bipolar Disord 2000; 2:305–315

Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R: Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affective Disord 2000; 59(suppl 1):S5–S30

Akiskal HS, Pinto O: The evolving bipolar spectrum: prototypes I, II, III, and IV. Psychiatr Clin North Am 1999; 22:517–534

Baldessarini RJ, Tondo L, Hennen J: Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 1999; 60(suppl 2):77–84

Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L: A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 1999; 60:733–740

Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ: Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999; 156:1164–1169

Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (Lamictal 602 Study Group): A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999; 60:79–88

Frank E, Swartz HA, Mallinger AG, Thase ME, Weaver EV, Kupfer DJ: Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol 1999; 108:579–587

Manji HK, Moore GJ, Chen G: Lithium at 50: have the neuroprotective effects of this unique medication been overlooked? Biol Psychiatry 1999; 46:929–940

Ghaemi SN, Boiman EE, Goodwin FK: Kindling and second messengers: an approach to the neurobiology of recurrence in bipolar disorder. Biol Psychiatry 1999; 45:137–144

Viguera AC, Cohen LS: The course and management of bipolar disorder during pregnancy. Psychopharmacol Bull 1998; 34:339–346

Maj M, Pirozzi R, Magliano L, Bartoli L: Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998; 155:30–35

Keck PE Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML, Haggard P: 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998; 155:646-652

Tondo L, Baldessarini RJ: Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry 1998; 155:1434–1436

Post RM, Frye MA, Denicoff KD, Leverich GS, Kimbrell TA, Dunn RT: Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 1998; 19:206–219

Geller B, Luby J: Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997; 36:1168–1176

Soares JC, Mann JJ: The anatomy of mood disorders: review of structural neuroimaging studies. Biol Psychiatry 1997; 41:86–106

Hyman SE, Nestler EJ: Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996; 153:151–162

Jefferson JW: Lithium, in Predictors of Treatment Response in Mood Disorders. Edited by Goodnick PJ. Washington DC, American Psychiatric Press, 1996, pp 95–117

Angst J, Preisig M: Outcome of a clinical cohort of unipolar, bipolar, and schizoaffective patients: results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 1995; 146:17–23

Kovacs M, Pollock M: Bipolar disorder and comorbid conduct disorder in childhood and adolescence. J Am Acad Child Adolesc Psychiatry 1995; 34:715–723

Goldberg JF, Harrow M, Grossman LS: Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 1995; 152:379–384

Strober M, Schmidt-Lackner S, Freeman R, Bower S, Lampert C, DeAntonio M: Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995; 34:724–731

Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG (Depakote Mania Study Group): Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271:918–924

Jarrett RB, Rush AJ: Short-term psychotherapy of depressive disorders: current status and future directions. Psychiatry 1994; 57:115–132

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC, American Psychiatric Association, 1994, pp 292–296, 378–380

McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda GL, Swann AC: Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992; 149:1633–1644

Carlson GA, Rapport MD, Pataki CS, Kelly KL: Lithium in hospitalized children at 4 and 8 weeks: mood, behavior, and cognitive effects. J Child Psychol Psychiatry 1992; 33:411–425

Post RM, Leverich GS, Altshuler L, Mikalauskas K: Lithium-discontinuation-induced refractoriness: preliminary observations. Am J Psychiatry 1992; 149:1727–1729

Jamison KR: Manic-depressive illness: the overlooked need for psychotherapy, in Integrating Pharmacotherapy and Psychotherapy. Edited by Beitman BD, Klerman GL. Washington, DC, American Psychiatric Press, 1991, pp 409–420

Suppes T, Baldessarini RJ, Faedda GL, Tohen M: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48:1082–1088

Tsuang MT, Faraone SV: The Genetics of Mood Disorders. Baltimore, Johns Hopkins University Press, 1990

Tomasson K, Kuperman S: Bipolar disorder in a prepubescent child. J Am Acad Child Adolesc Psychiatry 1990; 29:308–310

Post RM: Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 1990; 23:3–17

Schou M: Lithium prophylaxis: myths and realities. Am J Psychiatry 1989; 146:573–576

Wehr TA, Goodwin FK: Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144:1403–1411

Dunner DL, Fieve RR: Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30:229–233

Janowsky DS, el-Yousef MK, Davis JM: Interpersonal maneuvers of manic patients. Am J Psychiatry 1974;131:250-255.

Prien RF, Caffey EM Jr, Klett CJ: Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972; 26:146–153

Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ: A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972; 2(7778):632–635